Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ST-067 |
Trade Name | |
Synonyms | ST067|ST 067|Vevoctadekin |
Drug Descriptions |
ST-067 is a modified version of IL-18, which activates the IL-18 receptor, potentially leading to enhanced antitumor immune response (NCI Thesaurus). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C181677 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Obinutuzumab + ST-067 | Obinutuzumab ST-067 | 0 | 1 |
Pembrolizumab + ST-067 | Pembrolizumab ST-067 | 0 | 1 |
ST-067 | ST-067 | 0 | 2 |